Compugen Ltd. (CGEN) Reports 2nd Quarter 2014 Financial Results
8/6/2014 9:28:53 AM
Compugen Ltd. (NASDAQ: CGEN) today reported financial results for the second quarter ending June 30, 2014.
Dr. Anat Cohen-Dayag, Compugen’s President and CEO, stated, "During the first six months of this year, our R&D efforts focused primarily on advancing product candidates in our Pipeline Program, diversifying the pipeline with additional target candidates for antibody-based therapy, and extending our capabilities to enable the validation and development of multiple product candidates in parallel.
Help employers find you! Check out all the jobs and post your resume.
comments powered by